Chronic Necrotizing Pulmonary Aspergillosis

Re, Binder; Lj, Faling; Pugatch, Robert D.; Mahasaen, Choompol; Gl, Snider

doi:10.1097/00005792-198203000-00005

Cited by 354 publications

(259 citation statements)

References 0 publications

Supporting

Mentioning

231

Contrasting

Unclassified

Order By: Relevance

“…Binder et al proposed the concept that chronic necrotizing pulmonary aspergillosis is the chronic form of invasive pulmonary aspergillosis (1). Whichof these forms occur maybedependent on the reciprocal action of the host immune system and the pathogenicity of aspergillus species (1)(2)(3). In this case, the time from hospital visit to death was one year.…”

Section: Discussionmentioning

confidence: 99%

Invasive Pulmonary Aspergillosis with Thrombosis in the Left Atrium.

et al. 2001

View full text Add to dashboard Cite

Wereport a female patient with left atrial wall invasion from pulmonary aspergillosis. She had been treated for diabetes mellitus. Pulmonary aspergillosis extended to the left atrial wall via the left pulmonary vein and formed a polypoid lesion in the left atrium. The polypoid lesion was composed of thrombus, and the thrombus increased in size to become large, and it showed invagination into the mitral valve during diastole. Weconsidered that the thrombus was formed on the injured endocardium. Severe invasive aspergillosis thus could occur in a mild systemic immunocompromisedhost. (Internal Medicine 40: 250-254, 2001)

show abstract

Section: Discussionmentioning

confidence: 99%

Invasive Pulmonary Aspergillosis with Thrombosis in the Left Atrium.

et al. 2001

View full text Add to dashboard Cite

show abstract

“…Chronic pulmonary aspergillosis (CPA) was originally established in the early 1980s by Binder as chronic necrotizing pulmonary aspergillosis (CNPA) [1] and semi-invasive aspergillosis (SIA) by Gefter [2]. CNPA/SIA is characterized by a slow progressive cavitating process in the lungs due to Aspergillus spp.…”

Section: Introductionmentioning

confidence: 99%

Pathogenesis and clinical features of chronic pulmonary aspergillosis – Is it possible to distinguish CNPA and CCPA clinically?

Izumikawa

Tashiro

et al. 2014

Journal of Infection and Chemotherapy

View full text Add to dashboard Cite

“…1,2 Several names of these chronic forms of disease have been proposed: semi-invasive aspergillosis 3 , chronic necrotizing pulmonary aspergillosis (CNPA) 4 , simple or complex aspergilloma, and chronic cavitary and fibrosing pulmonary aspergillosis (CCPA and CFPA). 5 As Hope et al 6 indicated apparently distinct entities do not exist for this syndrome and these forms usually overlap.…”

Section: Introductionmentioning

confidence: 99%

Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: A multicenter trial in Japan

Kohno

Izumikawa

Ogawa

et al. 2010

Journal of Infection

106

129

View full text Add to dashboard Cite

SUMMARYChronic pulmonary aspergillosis (CPA) is slowly progressive inflammatory pulmonary syndrome due to Aspergillus spp. The evidence regarding CPA treatment is limited. We conducted a randomized, multicenter, open-label trial comparing intravenous micafungin (MCFG) of 150-300 mg once daily with intravenous voriconazole (VRCZ) of 6 mg/kg twice on Day 1 followed by 4 mg/kg twice daily for the treatment of 107 inpatients with CPA to compare the efficacy and safety of both drugs as initial treatment in Japan.

show abstract

Chronic Necrotizing Pulmonary Aspergillosis

Cited by 354 publications

References 0 publications

Invasive Pulmonary Aspergillosis with Thrombosis in the Left Atrium.

Invasive Pulmonary Aspergillosis with Thrombosis in the Left Atrium.

Pathogenesis and clinical features of chronic pulmonary aspergillosis – Is it possible to distinguish CNPA and CCPA clinically?

Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: A multicenter trial in Japan

Contact Info

Product

Resources

About